Yazar "Bragazzi N. L." için Makale Koleksiyonu listeleme
-
Higher rates of COVID-19 but less severe infections reported for patients on dupilumab: A big data analysis of the world health organization vigibase
Mahroum, Naim; Damiani, G.; Watad, A.; Amital, H.; Bragazzi N. L.; Farah, R.; Wu, J.; Kong, J.D.; Bridgewood, C.; Mcgonagle, D.; Khamisy-Farah, R. (Verduci Editore s.r.l, 2021)Objective: Dupilumab (Dupixent ®) is a monoclonal antibody that inhibits IL- 4 and IL-13 signaling used for the treatment of allergic diseases. Whilst biologic therapy is traditionally regarded as immunosuppressive and ...